Enzon Pharmaceuticals, Inc. (ENZN)

0.0553 -0.02 (-22.11%) USD  |  OTCM  |  Feb 25, 16:00
More

Enzon Pharmaceuticals Interest Paid Supplemental Data (Quarterly)

Interest Paid Supplemental Data (Quarterly) Chart

View Interest Paid Supplemental Data (Quarterly) for ENZN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Interest Paid Supplemental Data (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Interest Paid Supplemental Data (Quarterly) Range, Past 5 Years

View Interest Paid Supplemental Data (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Interest Paid Supplemental Data (Quarterly) Benchmarks

View Interest Paid Supplemental Data (Quarterly) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
LadRx Corp. Upgrade
Plus Therapeutics, Inc. Upgrade
Windtree Therapeutics, Inc. Upgrade